| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Revenue | $36.0M | +219.3% |
| Cost of Revenue | $26.9M | +283.6% |
| Gross Profit | $9.2M | — |
| R&D Expense | $23K | — |
| SG&A Expense | $5.4M | — |
| Operating Income | $192K | — |
| Interest Expense | $0 | — |
| Pre-tax Income | $463K | — |
| Income Tax | $419K |
| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.9M | -11.0% |
| Accounts Receivable | $2.6M | +49.8% |
| Inventory | $1.1M | — |
| Current Assets | $19.3M | -3.8% |
| Total Assets | $32.6M | +59.2% |
| Current Liabilities | $2.7M | +101.3% |
| Total Liabilities | $2.8M | +81.3% |
| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.8M | — |
| Investing Cash Flow | -$4.4M | — |
| Financing Cash Flow | $32K | — |
| Net Income | -$250K | — |
| EPS (Basic) | -$0.01 | — |
| EPS (Diluted) | -$0.01 | — |
| Stockholders' Equity |
| $29.8M |
| +57.4% |